Laura Zorzino

Dietary patterns and change in food consumption in overweight or obese breast cancer survivors: the InForma randomized intervention trial

Patrizia Gnagnarella, Giulia Carioni, Daniele Dragà, Silvia Raja et autres

it (code pays fourni par la source)

PIK3CA mutation analysis in circulating tumor cells of patients with hormone receptor positive metastatic breast cancer

Elena Marino, Cristian Mauro, Elena Belloni, M. Picozzi et autres

mutation. No pathogenic germline variants were found. Our data support the conclusion that CTCs analysis may be used to identify mutations in patients to identify those more likely to metastasize.

it (code pays fourni par la source)

Physical activity and/or dietary intervention in overweight or obese breast cancer survivors: results of the InForma randomized trial

Patrizia Gnagnarella, Daniele Dragà, Silvia Raja, Federica Baggi et autres

it (code pays fourni par la source)

Diagnostic Performance and Cell Count of EBUS–TBNA Needle Gauges: A Prospective Trial

Juliana Guarize, Cristina Diotti, Monica Casiraghi, Stefano Donghi et autres

Background. Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a well-established diagnostic procedure for evaluating hilar and mediastinal lymphadenopathies and is the gold standard for lung cancer diagnosis and staging. Recent studies assessed the effectiveness of the 19-G flex needle in obtaining larger …

it (code pays fourni par la source)

Intraoperative Extra Corporeal Membrane Oxygenator for Lung Cancer Resections Does Not Impact Circulating Tumor Cells

Francesco Petrella, Laura Zorzino, Samuele Frassoni, Vincenzo Bagnardi et autres

Background: The diagnosis of active neoplastic disease was traditionally judged an absolute contraindication for extracorporeal membrane oxygenator (ECMO) because of the fear of tumor cells being scattered or seeded. The aim of this study is to compare the number of circulating tumor …

it (code pays fourni par la source)

Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes

Chiara Alessandra Cella, Francesca Spada, Alfredo Berruti, Francesco Bertolini et autres

BACKGROUND: The success of targeted therapies in the treatment of pancreatic neuroendocrine tumors has emphasized the strategy of targeting angiogenesis and the PI3K/AKT/mTOR pathway. However, the major challenge in the targeted era remains the early identification of resistant tumors especially when the …

it (code pays fourni par la source)

POS0424 DETERMINING CIRCULATING ENDOTHELIAL CELLS USING CELLSEARCH SYSTEM IN SYSTEMIC SCLEROSIS PATIENTS

Francesca Serena Pignataro, Laura Zorzino, Wanda Maglione, Antonina Minniti et autres

it, es, gb (code pays fourni par la source)

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Massimo Cristofanilli, Jean‐Yves Pierga, James Mwikya Reuben, ALFRED W. RADEMAKER et autres

us, fr, be, de, it, es, gr, gb, au (code pays fourni par la source)

Serum HER2 Extracellular Domain Levels and Her2 Circulating Tumor Cell Status in Patients with Metastatic Breast Cancer

Gaetano Aurilio, Maria Teresa Sandri, Giancarlo Pruneri, Laura Zorzino et autres

AIM: To shed light on the clinical role of HER2 status in serum as extracellular domain (ECD) and corresponding circulating tumor cells (CTCs) in metastatic breast cancer patients. METHODS: 68 patients were analyzed. Serum HER2 was determined by ADVIA Centaur(®) Serum HER2 …

it (code pays fourni par la source)

Abstract P2-08-08: Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis

F-C Bidard, Dieter J. E. Peeters, Tanja Natascha Fehm, Franco Nolè et autres

Abstract Background: The European Pooled Analysis of CTC (EPAC) in metastatic breast cancer, based on 1,944 individual data from patients with various tumor types and clinical settings (Bidard et al, Lancet Oncol 2014), has established CTC count (CellSearch) at baseline and during …

us, de, es, gr, it (code pays fourni par la source)

Clinical outcome of circulating tumor cells in metastatic castration-resistant prostate cancer patients treated with docetaxel: long-term prospective single-centre study

Elena Verri, Gaetano Aurilio, Maria Cossu Rocca, Maria Teresa Sandri et autres

it (code pays fourni par la source)

Diffusion-MRI and angiogenic profiling in patients with advanced well-differentiated pancreatic neuroendocrine tumors treated with everolimus

Chiara Alessandra Cella, Francesca Spada, Salvatore Galdy, Anna Maria Frezza et autres

it (code pays fourni par la source)